Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.7K Sell
709
-157
-18% -$3.7K ﹤0.01% 1801
2026
Q1
$19.7K Buy
866
+173
+25% +$4.09K ﹤0.01% 1612
2025
Q4
$18.5K Sell
693
-142
-17% -$4.2K ﹤0.01% 1591
2025
Q3
$25.3K Buy
835
+313
+60% +$9.49K ﹤0.01% 1373
2025
Q2
$16.4K Sell
522
-132
-20% -$4.37K ﹤0.01% 1446
2025
Q1
$25K Sell
654
-124
-16% -$5.26K ﹤0.01% 1273
2024
Q4
$34.1K Buy
778
+437
+128% +$19.2K ﹤0.01% 1062
2024
Q3
$14.7K Sell
341
-39
-10% -$1.74K ﹤0.01% 1342
2024
Q2
$17.2K Buy
380
+174
+84% +$9.03K ﹤0.01% 1126
2024
Q1
$12.9K Hold
206
﹤0.01% 1228
2023
Q4
$11.5K Sell
206
-389
-65% -$19.4K ﹤0.01% 1251
2023
Q3
$31.4K Buy
+595
New +$34.7K ﹤0.01% 957
2022
Q3
Sell
-166
Closed -$10K 1808
2022
Q2
$10K Sell
166
-130
-44% -$8.38K ﹤0.01% 1391
2022
Q1
$21K Sell
296
-8
-3% -$570 ﹤0.01% 1230
2021
Q4
$24K Buy
+304
New +$25.4K ﹤0.01% 1215

Other funds holding ENOV

UMB Bank's ENOV Position: Q2 2026 in Review

UMB Bank reduced its Enovis (ENOV) stake by 18% in Q2 2026, selling an estimated $3.7K and leaving 709 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1801.

UMB Bank first reported a position in ENOV in Q4 2021 and has held it in 15 quarters since. The position peaked at $34.1K in Q4 2024. 254 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • UMB Bank held 709 shares of Enovis worth $14.7K as of Q2 2026.
  • UMB Bank sold 157 Enovis shares in Q2 2026, an estimated $3.7K.
  • Enovis made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1801 holding.
  • UMB Bank first reported a position in Enovis in Q4 2021 and has held it in 15 quarters since.
  • UMB Bank's Enovis position peaked at $34.1K in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.